相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Olaparib Combined with an ATR or Chk1 Inhibitor as a Treatment Strategy for Acquired Olaparib-Resistant BRCA1 Mutant Ovarian Cells
Brian T. Burgess et al.
DIAGNOSTICS (2020)
F-Box Protein-Mediated Resistance to PARP Inhibitor Therapy
Aleksandra I. Adamovich et al.
MOLECULAR CELL (2019)
PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells
Sylvie M. Noordermeer et al.
TRENDS IN CELL BIOLOGY (2019)
The F-Box Domain-Dependent Activity of EMI1 Regulates PARPi Sensitivity in Triple-Negative Breast Cancers
Antonio Marzio et al.
MOLECULAR CELL (2019)
Mechanisms of PARP inhibitor sensitivity and resistance
Alan D. D'Andrea
DNA REPAIR (2018)
Reverse the Resistance to PARP Inhibitors
Yevgeniy Kim et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2017)
Progression through mitosis promotes PARP inhibitor-induced cytotoxicity in homologous recombination-deficient cancer cells
Pepijn M. Schoonen et al.
NATURE COMMUNICATIONS (2017)
The selective MEK1 inhibitor Selumetinib enhances the antitumor activity of everolimus against renal cell carcinoma in vitro and in vivo
Yun Zou et al.
ONCOTARGET (2017)
High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities
Traver Hart et al.
CELL (2015)
Gene essentiality and synthetic lethality in haploid human cells
Vincent A. Blomen et al.
SCIENCE (2015)
Identification and characterization of essential genes in the human genome
Tim Wang et al.
SCIENCE (2015)
Stereospecific PARP Trapping by BMN 673 and Comparison with Olaparib and Rucaparib
Junko Murai et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Emi1 preferentially inhibits ubiquitin chain elongation by the anaphase-promoting complex
Weiping Wang et al.
NATURE CELL BIOLOGY (2013)
EMI1, a three-in-one ubiquitylation inhibitor
Hiroyuki Yamano
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
MEK1/2 Inhibitor Selumetinib (AZD6244) Inhibits Growth of Ovarian Clear Cell Carcinoma in a PEA-15-Dependent Manner in a Mouse Xenograft Model
Chandra Bartholomeusz et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Knockdown of Rad51 expression induces radiation- and chemo-sensitivity in osteosarcoma cells
Li-Qing Du et al.
MEDICAL ONCOLOGY (2011)
Identification of Breast Tumor Mutations in BRCA1 That Abolish Its Function in Homologous DNA Recombination
Derek J. R. Ransburgh et al.
CANCER RESEARCH (2010)
Overexpression of RAD51 suppresses recombination defects: a possible mechanism to reverse genomic instability
David Schild et al.
NUCLEIC ACIDS RESEARCH (2010)
PARP inhibition: PARP1 and beyond
Michele Rouleau et al.
NATURE REVIEWS CANCER (2010)
Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer
Deann P. Atchley et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The APC/C inhibitor, Emi1, is essential for prevention of rereplication
Yuichi J. Machida et al.
GENES & DEVELOPMENT (2007)
A stronger DNA damage-induced G2 checkpoint due to over-activated CHK1 in the absence of PARP-1
Hua-Rui Lu et al.
CELL CYCLE (2006)
Mouse emi1 has an essential function in mitotic progression during early embryogenesis
Ho Lee et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
Prophase destruction of Emi1 by the SCFβTrCP/Slimb ubiquitin ligase activates the anaphase promoting complex to allow progression beyond prometaphase
F Margottin-Goguet et al.
DEVELOPMENTAL CELL (2003)
RAD51 is involved in repair of damage associated with DNA replication in mammalian cells
C Lundin et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Overexpression of a protein fragment of RNA helicase A causes inhibition of endogenous BRCA1 function and defects in ploidy and cytokinesis in mammary epithelial cells
BP Schlegel et al.
ONCOGENE (2003)
Emi1 is a mitotic regulator that interacts with Cdc20 and inhibits the anaphase promoting complex
JDR Reimann et al.
CELL (2001)
p53 splice acceptor site mutation and increased HsRAD51 protein expression in Bloom's syndrome GM1492 fibroblasts
KP Magnusson et al.
GENE (2000)
分享论文
